Chao Xu, Ph.D. - Publications
Affiliations: | 2011 | Pharmaceutical Sciences | State University of New York, Buffalo, Buffalo, NY, United States |
Year | Citation | Score | |||
---|---|---|---|---|---|
2012 | Mager DE, Mody V, Xu C, Forrest A, Lesniak WG, Nigavekar SS, Kariapper MT, Minc L, Khan MK, Balogh LP. Physiologically based pharmacokinetic model for composite nanodevices: effect of charge and size on in vivo disposition. Pharmaceutical Research. 29: 2534-42. PMID 22688900 DOI: 10.1007/S11095-012-0784-7 | 0.49 | |||
2011 | Xu C, Mager DE. Quantitative structure-pharmacokinetic relationships. Expert Opinion On Drug Metabolism & Toxicology. 7: 63-77. PMID 21105864 DOI: 10.1517/17425255.2011.537257 | 0.533 | |||
2010 | Xu C, Barchet TM, Mager DE. Quantitative structure–property relationships of camptothecins in humans. Cancer Chemotherapy and Pharmacology. 65: 325-33. PMID 19488755 DOI: 10.1007/S00280-009-1037-2 | 0.534 | |||
2009 | Walker JR, Brown K, Rohatagi S, Bathala MS, Xu C, Wickremasingha PK, Salazar DE, Mager DE. Quantitative structure-property relationships modeling to predict in vitro and in vivo binding of drugs to the bile sequestrant, colesevelam (Welchol). Journal of Clinical Pharmacology. 49: 1185-95. PMID 19783712 DOI: 10.1177/0091270009340783 | 0.522 | |||
Show low-probability matches. |